Suppr超能文献

在检测血清中SARS-CoV-2病毒标志物蛋白时,利用噬菌体的自我复制机制进行基于聚合酶链式反应(PCR)的级联信号放大。

Hijacking the self-replicating machine of bacteriophage for PCR-based cascade signal amplification in detecting SARS-CoV-2 viral marker protein in serum.

作者信息

Du Jialei, Xiang Daili, Liu Fushan, Wang Leichen, Li Hao, Gong Liu, Fan Xiangyu

机构信息

Institute for Advanced Interdisciplinary Research (iAIR), Collaborative Innovation Center of Technology and Equipment for Biological Diagnosis and Therapy in Universities of Shandong, University of Jinan, Jinan 250022, China.

School of Biological Science and Technology, University of Jinan, Jinan 250024, China.

出版信息

Sens Actuators B Chem. 2023 Jan 1;374:132780. doi: 10.1016/j.snb.2022.132780. Epub 2022 Oct 14.

Abstract

In this work, the nucleic acid detection of SARS-Cov-2 is extended to protein markers of the virus, utilizing bacteriophage. Specifically, the phage display technique enables the main protease of SARS-Cov-2 to control the self-replication of m13 phage, so that the presence of the viral protease can be amplified by phage replication as the first round of signal amplification. Then, the genome of replicated phage can be detected using polymer chain reaction (PCR), as the second round of signal amplification. Based on these two types of well-established biotechnology, the proposed method shows satisfactory sensitivity and robustness in the direct serum detection of the viral protease. These results may point to clinical application in the near future.

摘要

在这项工作中,利用噬菌体将严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的核酸检测扩展到该病毒的蛋白质标志物。具体而言,噬菌体展示技术使SARS-CoV-2的主要蛋白酶能够控制M13噬菌体的自我复制,从而使病毒蛋白酶的存在能够通过噬菌体复制进行扩增,作为第一轮信号放大。然后,可使用聚合酶链反应(PCR)检测复制噬菌体的基因组,作为第二轮信号放大。基于这两种成熟的生物技术,所提出的方法在病毒蛋白酶的直接血清检测中显示出令人满意的灵敏度和稳健性。这些结果可能预示着在不久的将来可应用于临床。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11b4/9560943/b0e1ee02fa73/ga1_lrg.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验